Champions Oncology Short Interest Ratio and Short Volume

+0.10 (+0.89 %)
(As of 04/21/2021 12:00 AM ET)
Today's Range
Now: $11.30
50-Day Range
MA: $11.72
52-Week Range
Now: $11.30
Volume14,558 shs
Average Volume31,324 shs
Market Capitalization$151.31 million
P/E RatioN/A
Dividend YieldN/A

Short Interest

Champions Oncology (NASDAQ:CSBR) Short Interest Data

Current Short Volume159,600 shares
Previous Short Volume144,300 shares
Change Vs. Previous Month+10.60%
Dollar Volume Sold Short$1.81 million
Short Interest Ratio / Days to Cover4.9
Last Record DateMarch, 31 2021
Outstanding Shares13,390,000 shares
Float Size4,130,000 shares
Short Percent of Float3.86%
Today's Trading Volume14,558 shares
Average Trading Volume31,324 shares
Today's Volume Vs. Average-53.52%

Short Interest Over Time

Champions Oncology (NASDAQ:CSBR) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/31/2021159,600 shares $1.81 million +10.6%3.9%4.9 $11.35
3/15/2021144,300 shares $1.80 million -6.2%3.5%4 $12.50
2/26/2021153,800 shares $1.70 million +9.7%3.8%4.2 $11.05
2/12/2021140,200 shares $1.64 million +7.1%3.4%4 $11.68
1/29/2021130,900 shares $1.51 million +6.5%2.0%3.8 $11.51
1/15/2021122,900 shares $1.39 million No Change1.9%3.4 $11.33
1/31/2020120,000 shares $852,000.00 -6.5%2.5%2.1 $7.10
1/15/2020120,000 shares $859,200.00 -6.5%2.5%2.1 $7.16
12/31/2019128,400 shares $1.06 million +6.7%2.6%2.4 $8.24
8/15/2019207,900 shares $1.30 million -3.0%4.9%7.6 $6.25

Champions Oncology (NASDAQ:CSBR) Short Interest FAQ

speech bubbles
speech bubbles

What is Champions Oncology's current short interest?

Short interest is the volume of Champions Oncology shares that have been sold short but have not yet been covered or closed out. As of March 31st, traders have sold 159,600 shares of CSBR short. 3.86% of Champions Oncology's shares are currently sold short. View details.

What is a good short interest ratio for Champions Oncology?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. Champions Oncology currently has a short interest ratio of 5.0.

What is a good short interest percentage for Champions Oncology?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.86% of Champions Oncology's floating shares are currently sold short.

Is Champions Oncology's short interest increasing or decreasing?

Champions Oncology saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 159,600 shares, an increase of 10.6% from the previous total of 144,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Champions Oncology's float size?

Champions Oncology currently has issued a total of 13,390,000 shares. Some of Champions Oncology's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Champions Oncology currently has a public float of 4,130,000 shares.

How does Champions Oncology's short interest compare to its competitors?

3.86% of Champions Oncology's shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Champions Oncology: Tarsus Pharmaceuticals, Inc. (4.81%), Agenus Inc. (0.00%), Compugen Ltd. (0.00%), Poseida Therapeutics, Inc. (11.26%), Solid Biosciences Inc. (0.00%), Precision BioSciences, Inc. (13.46%), Oyster Point Pharma, Inc. (10.36%), AVROBIO, Inc. (0.00%), Gritstone Oncology, Inc. (8.79%), and Aptose Biosciences Inc. (5.86%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Analog Devices, Inc. ($5.84 billion), Aon plc ($5.47 billion), Charter Communications, Inc. ($5.36 billion), ViacomCBS Inc. ($3.99 billion), Snap Inc. ($3.77 billion), Airbnb, Inc. ($2.90 billion), Peloton Interactive, Inc. ($2.43 billion), Discovery, Inc. ($2.38 billion), The Kroger Co. ($2.28 billion), and Expedia Group, Inc. ($2.18 billion). View all of the most shorted stocks.

What does it mean to sell short Champions Oncology stock?

Short selling CSBR is an investing strategy that aims to generate trading profit from Champions Oncology as its price is falling. Champions Oncology's stock is trading up $0.10 today. To short Champions Oncology stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Champions Oncology will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Champions Oncology?

A short squeeze for Champions Oncology occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CSBR, which in turn drives the price of the stock up even further.

How often is Champions Oncology's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CSBR, twice per month. The most recent reporting period available is March, 31 2021.

This page was last updated on 4/21/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.